{
  "ticker": "VRTX",
  "year": 2023,
  "quarter": 3,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 13,
  "transactions": [
    {
      "id": 118549,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2023-09-29",
      "transaction_shares": "408",
      "transaction_price": "350.72",
      "transaction_type": "F",
      "shares_after_transaction": "11179"
    },
    {
      "id": 118602,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-09-19",
      "transaction_shares": "5651",
      "transaction_price": "351.00",
      "transaction_type": "S",
      "shares_after_transaction": "51905"
    },
    {
      "id": 118654,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-09-05",
      "transaction_shares": "5651",
      "transaction_price": "352.66",
      "transaction_type": "S",
      "shares_after_transaction": "57556"
    },
    {
      "id": 118650,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-08-23",
      "transaction_shares": "2500",
      "transaction_price": "355.00",
      "transaction_type": "S",
      "shares_after_transaction": "48637"
    },
    {
      "id": 118590,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "10000",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "16536"
    },
    {
      "id": 118610,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-08-10",
      "transaction_shares": "5750",
      "transaction_price": "345.79",
      "transaction_type": "S",
      "shares_after_transaction": "51137"
    },
    {
      "id": 118678,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-08-10",
      "transaction_shares": "10031",
      "transaction_price": "350.00",
      "transaction_type": "S",
      "shares_after_transaction": "58814"
    },
    {
      "id": 118592,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-09",
      "transaction_shares": "242",
      "transaction_price": "345.51",
      "transaction_type": "S",
      "shares_after_transaction": "4386"
    },
    {
      "id": 118620,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-08-09",
      "transaction_shares": "63",
      "transaction_price": "345.51",
      "transaction_type": "S",
      "shares_after_transaction": "32038"
    },
    {
      "id": 76603,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-07-17",
      "transaction_shares": "7828",
      "transaction_price": "355.00",
      "transaction_type": "S",
      "shares_after_transaction": "118906"
    },
    {
      "id": 76627,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-17",
      "transaction_shares": "11250",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "51250"
    },
    {
      "id": 118641,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-07-17",
      "transaction_shares": "7828",
      "transaction_price": "355.00",
      "transaction_type": "S",
      "shares_after_transaction": "118906"
    },
    {
      "id": 118668,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-17",
      "transaction_shares": "11250",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "51250"
    }
  ]
}